Celastrol ameliorates metabolic dysfunction associated steatohepatitis by regulating the CYP7B1-mediated alternative bile acid synthetic pathway
{{output}}
Background: Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease driven by steatosis, inflammation, and fibrosis. Celastrol (CEL), a natural bioactive compound, has exhibited promise in preclinic... ...
